Robuta

https://pubmed.ncbi.nlm.nih.gov/25249176/
Type 2 diabetes and cancer: should we prefer antihyperglycaemic treatments without unnecessarily increasing insulin levels?
typediabetescancerpreferantihyperglycaemic